BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2161897)

  • 1. The risk factors in the development of persistent trophoblastic disease following hydatidiform mole.
    Tangtrakul S; Srisupundit S; Linasmita V; Bullangpoti S; Bhamarapravati Y
    J Med Assoc Thai; 1990 Feb; 73 Suppl 1():33-6. PubMed ID: 2161897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Statistical analysis of trophoblastic disease in Kanagawa prefecture].
    Iwata Y; Amemiya K; Uchida K; Okajima H; Kuramoto H; Kenjo T; Koshimizu T; Kosuge O; Gotoda Y; Saito M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jan; 41(1):48-54. PubMed ID: 2538525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent gestational trophoblastic disease after hCG normalization following hydatidiform mole in The Netherlands.
    Kerkmeijer LG; Wielsma S; Massuger LF; Sweep FC; Thomas CM
    Gynecol Oncol; 2007 Jul; 106(1):142-6. PubMed ID: 17462723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of persistent disease in women with complete hydatidiform mole.
    Ayhan A; Tuncer ZS; Halilzade H; Küçükali T
    J Reprod Med; 1996 Aug; 41(8):591-4. PubMed ID: 8866387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complete hydatidiform mole and a coexistent viable fetus: report of two cases and review of the literature.
    Bruchim I; Kidron D; Amiel A; Altaras M; Fejgin MD
    Gynecol Oncol; 2000 Apr; 77(1):197-202. PubMed ID: 10739712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant potential of gestational trophoblastic disease at the extreme ages of reproductive life.
    Bandy LC; Clarke-Pearson DL; Hammond CB
    Obstet Gynecol; 1984 Sep; 64(3):395-9. PubMed ID: 6087230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The natural history of theca lutein cysts.
    Montz FJ; Schlaerth JB; Morrow CP
    Obstet Gynecol; 1988 Aug; 72(2):247-51. PubMed ID: 2455880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [New trends in trophoblastic disease].
    Obata N
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1582-7. PubMed ID: 2543315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Twin pregnancy consisting of 46, XY heterozygous complete mole coexisting with a live fetus.
    Kashimura Y; Tanaka M; Harada N; Shinmoto M; Morishita T; Morishita H; Kashimura M
    Placenta; 2001 Apr; 22(4):323-7. PubMed ID: 11286568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The problem of identification of prognostic factors for persistent trophoblastic disease.
    Parazzini F; Mangili G; Belloni C; La Vecchia C; Liati P; Marabini R
    Gynecol Oncol; 1988 May; 30(1):57-62. PubMed ID: 2835296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of contraception in the development of postmolar gestational trophoblastic tumor.
    Deicas RE; Miller DS; Rademaker AW; Lurain JR
    Obstet Gynecol; 1991 Aug; 78(2):221-6. PubMed ID: 1648697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the risk of persistent trophoblastic disease after twin pregnancy with diploid hydatidiform mole and coexisting normal fetus.
    Niemann I; Sunde L; Petersen LK
    Am J Obstet Gynecol; 2007 Jul; 197(1):45.e1-5. PubMed ID: 17618752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theca lutein ovarian cyst may be pathognomonic for trophoblastic neoplasia.
    Kohorn EI
    Obstet Gynecol; 1983 Sep; 62(3 Suppl):80s-81s. PubMed ID: 6308531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Epidemiologic and clinicopathologic studies of partial hydatidiform mole].
    Kodama A; Kanazawa K; Honma S; Aoki Y; Tanaka K; Takahashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Sep; 43(9):1219-25. PubMed ID: 1919183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
    Osamor JO; Oluwasola AO; Adewole IF
    J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic features of sharp curettings in complete hydatidiform mole. Predictors of persistent gestational trophoblastic disease.
    Rice LW; Genest DR; Berkowitz RS; Goldstein DP; Bernstein MR; Redline RW
    J Reprod Med; 1991 Jan; 36(1):17-20. PubMed ID: 1848894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for gestational trophoblastic disease: a separate analysis of complete and partial hydatidiform moles.
    Parazzini F; Mangili G; La Vecchia C; Negri E; Bocciolone L; Fasoli M
    Obstet Gynecol; 1991 Dec; 78(6):1039-45. PubMed ID: 1945204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiologic features of hydatidiform mole in the Netherlands.
    Franke HR; Risse EK; Kenemans P; Vooijs GP; Stolk JG
    Obstet Gynecol; 1983 Nov; 62(5):613-6. PubMed ID: 6621952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of gestational trophoblastic disease: results of a cooperative study.
    Fasoli M; Ratti E; Franceschi S; La Vecchia C; Pecorelli S; Mangioni C
    Obstet Gynecol; 1982 Aug; 60(2):205-9. PubMed ID: 6296736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathogenesis of gestational trophoblastic neoplasms.
    Berkowitz RS; Goldstein DP
    Pathobiol Annu; 1981; 11():391-411. PubMed ID: 6276846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.